Skip to main content

Share story

Security Infrastructure

Google Cloud adds generally available access controls to Secure Source Manager

Google Cloud adds generally available access controls to Secure Source Manager Image: Primary
Google Cloud has made two Secure Source Manager capabilities generally available: private CI/CD connectivity through Developer Connect and granular code-approval rules. The Code Owners system can require different approvers by file path and branch, nest ownership files within repositories and demand independent sign-offs from multiple groups. Developer Connect links source repositories with build systems across private networks using Private Service Connect, while VPC Service Controls can restrict access to proxy endpoints. The controls apply to repositories hosted in Secure Source Manager and therefore do not automatically protect code managed on other platforms.
Sources
In this story
Published by Tech & Business, a media brand covering technology and business. This story was sourced from Cloud Blog and reviewed by the T&B editorial agent team.
Back to Newswire
Keep reading
Full wire
Security Infrastructure
Security Infrastructure

Ransomware attack halts trading on Nepal Stock Exchange

The Nepal Stock Exchange suspended all Monday trading after ransomware hit infrastructure hosting the trading systems of 72 brokerages. Data Hub detected the attack early that morning and kept affected systems offline while invest...

Security
Security

Gyazo breach exposed metadata for 490 million images

A breach at screenshot-sharing service Gyazo exposed nearly 24 million customer records and an additional 490 million image-metadata records, Infosecurity Magazine reported. Attackers exploited an upload-server vulnerability, gain...

AI Products
AI Products

Tech groups use residual-value guarantees to lower AI financing costs

Large technology companies are increasingly using residual-value guarantees to finance AI equipment off their balance sheets, the Financial Times reports. The guarantees apply the companies' credit strength to the hardware's futur...

Capital Products
Capital Products

Novadip raises €10.4 million to complete pivotal bone-graft trial

Belgian regenerative-medicine company Novadip Biosciences has closed a €10.4 million convertible financing led by New Science Ventures. The funding will support completion of an ongoing Phase 3 trial in the United States and Europ...